The Valley Desk

NCT06630806 · Interventional trial

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Overall registry status Recruiting

Phase 1

Conditions Plasma Cell Myeloma Refractory

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov